Search results
Results from the WOW.Com Content Network
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.
In November 2019, Mylan & Upjohn announced that the name of the new company would be Viatris. [ 84 ] [ 85 ] The company continued sales of Mylan's more than 7,500 products, including biosimilars, generics, brand and over-the-counter remedies, with brands including the Epi-Pen , Viagra , Lipitor and Celebrex .
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Revefenacin, sold under the brand name Yupelri, is a medication for the treatment of chronic obstructive pulmonary disease (COPD). It was approved for use in the United States in 2018. [1]
You are free: to share – to copy, distribute and transmit the work; to remix – to adapt the work; Under the following conditions: attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made.
The following other wikis use this file: Usage on de.wikipedia.org Viatris; Usage on fa.wikipedia.org ویاتریس; Usage on fr.wikipedia.org Viatris
Fondaparinux is a synthetic pentasaccharide factor Xa inhibitor. Fondaparinux binds antithrombin and accelerates its inhibition of factor Xa.. Apart from the O-methyl group at the reducing end of the molecule, the identity and sequence of the five monomeric sugar units contained in fondaparinux is identical to a sequence of five monomeric sugar units that can be isolated after either chemical ...
Alphapharm manufactures many different generic pharmaceutical medicines and exports to 50 countries. It is owned by Mylan Pharmaceuticals (USA) which merged with Upjohn on November 16, 2020, to become Viatris. Alphapharm's logo is a green circle with a white lowercase alpha enclosed.